Clinical trial / 2010
Soy supplementation improved somatic and urogenital menopausal symptoms over 16 weeks.
Sixty postmenopausal women aged 40 to 60 were randomly assigned to daily soy supplementation containing 90 mg of isoflavones, low-dose hormone therapy, or placebo for 16 weeks. Somatic symptoms decreased by 49.8% with soy and 45.6% with hormone therapy, while urogenital symptoms improved by 31.2% and 38.6%, respectively. Neither overall symptom ratings nor psychological subscale scores differed significantly among the groups.
- Study type
- Randomized controlled trial
- Who was studied
- 60 postmenopausal women aged 40-60
- What was measured
- Menopausal symptoms
THE PAPER
The effect of dietary soy supplementation compared to estrogen and placebo on menopausal symptoms: a randomized controlled trial.
Carmignani LO, Pedro AO, Costa-Paiva LH, Pinto-Neto AM. Maturitas, 2010.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.